A phase 2b/3 trial of Forvisirvat in major depressive disorder is investigating potential sex-specific antidepressant effects in women.
Joel Raskin, MD, FRCPC
Advertisement
Dr Raskin is a psychiatrist and the chief medical officer of Arrivo BioVentures LLC.
Articles by Joel Raskin, MD, FRCPC
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Psychiatric Times
1
Sex Differences, Sleep Problems, and Psychological Well-Being in Older Adults
2
Treating Patients With First-Episode Psychosis: Lessons From McLean OnTrack
3
Zolpidem: Restoring Sleep and Slowing Alzheimer Disease Progression
4
Sleep, Cognition, and the Bidirectional Brain, With Michael Scullin, PhD
5